Published in J Virol on July 21, 2010
Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc Natl Acad Sci U S A (2012) 2.14
Functional IRF3 deficiency in a patient with herpes simplex encephalitis. J Exp Med (2015) 1.71
Enhancing Interferon Regulatory Factor 7 Mediated Antiviral Responses and Decreasing Nuclear Factor Kappa B Expression Limit HIV-1 Replication in Cervical Tissues. PLoS One (2015) 1.42
A neuron-specific role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe (2012) 1.21
cGAS-mediated stabilization of IFI16 promotes innate signaling during herpes simplex virus infection. Proc Natl Acad Sci U S A (2015) 1.16
Herpes simplex virus γ34.5 interferes with autophagosome maturation and antigen presentation in dendritic cells. MBio (2012) 1.03
Neuronal Interferon Signaling Is Required for Protection against Herpes Simplex Virus Replication and Pathogenesis. PLoS Pathog (2015) 0.99
Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated? Future Microbiol (2011) 0.97
Synergistic control of herpes simplex virus pathogenesis by IRF-3, and IRF-7 revealed through non-invasive bioluminescence imaging. Virology (2013) 0.93
Role of the DNA Sensor STING in Protection from Lethal Infection following Corneal and Intracerebral Challenge with Herpes Simplex Virus 1. J Virol (2015) 0.92
Intrinsic innate immunity fails to control herpes simplex virus and vesicular stomatitis virus replication in sensory neurons and fibroblasts. J Virol (2014) 0.92
The Type I Interferon Response Determines Differences in Choroid Plexus Susceptibility between Newborns and Adults in Herpes Simplex Virus Encephalitis. MBio (2016) 0.85
Type I interferon signaling limits reoviral tropism within the brain and prevents lethal systemic infection. J Neurovirol (2011) 0.85
A NK complex-linked locus restricts the spread of herpes simplex virus type 1 in the brains of C57BL/6 mice. Immunol Cell Biol (2015) 0.82
CD200R1 supports HSV-1 viral replication and licenses pro-inflammatory signaling functions of TLR2. PLoS One (2012) 0.82
Δγ₁134.5 herpes simplex viruses encoding human cytomegalovirus IRS1 or TRS1 induce interferon regulatory factor 3 phosphorylation and an interferon-stimulated gene response. J Virol (2011) 0.81
Innate immune interactions within the central nervous system modulate pathogenesis of viral infections. Curr Opin Immunol (2015) 0.80
Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host? Prog Retin Eye Res (2013) 0.78
The Role of Plasmacytoid Dendritic Cells in Innate and Adaptive Immune Responses against Alpha Herpes Virus Infections. Adv Virol (2011) 0.78
Neurons versus herpes simplex virus: the innate immune interactions that contribute to a host-pathogen standoff. Future Virol (2015) 0.77
Neuronal IFN signaling is dispensable for the establishment of HSV-1 latency. Virology (2016) 0.76
Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure. J Virol (2016) 0.75
The Role of Herpes Simplex Virus Type 1 γ34.5 in the Regulation of IRF3 Signaling. J Virol (2017) 0.75
Differentiated SH-SY5Y human cells provide a reductionist model of HSV-1 neurotropism. J Virol (2017) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
A Toll-like receptor recognizes bacterial DNA. Nature (2000) 26.34
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol (2004) 26.12
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol (2005) 18.32
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science (2004) 16.26
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature (2007) 13.56
IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature (2005) 13.23
Antiviral actions of interferons. Clin Microbiol Rev (2001) 13.06
Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity (2000) 10.34
Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol (2001) 8.31
Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A (2006) 8.27
IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol (2006) 7.98
Viruses and interferon: a fight for supremacy. Nat Rev Immunol (2002) 7.92
Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA (2006) 7.46
Viruses and interferons. Annu Rev Microbiol (2001) 7.12
Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol (2002) 7.07
Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J (1998) 6.94
Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map. J Gen Virol (1973) 6.60
TLR3 deficiency in patients with herpes simplex encephalitis. Science (2007) 5.86
Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity (2006) 5.36
Herpes simplex virus encephalitis in human UNC-93B deficiency. Science (2006) 4.26
Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol (2008) 4.16
Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet (2003) 3.95
Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol (2005) 3.59
Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J Exp Med (1999) 3.45
Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J Virol (2000) 2.66
Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathog (2007) 2.54
Herpes simplex encephalitis: adolescents and adults. Antiviral Res (2006) 2.41
IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog (2010) 2.39
Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J Virol (2002) 2.38
The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J Virol (2004) 2.32
Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood (2001) 2.25
Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J Virol (2004) 2.24
Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun (2002) 2.19
Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J Virol (2002) 2.04
Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A (2006) 2.02
Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's. Herpes (2004) 1.98
In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts. J Gen Virol (1993) 1.93
Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J Virol (2008) 1.92
Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol (2004) 1.91
Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol (2005) 1.88
Herpes simplex keratitis. Prog Retin Eye Res (2006) 1.81
Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1. J Biol Chem (2008) 1.76
Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am J Pathol (2000) 1.72
MyD88 as a bottle neck in Toll/IL-1 signaling. Curr Top Microbiol Immunol (2002) 1.71
Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3. J Gen Virol (2006) 1.66
Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis (1996) 1.66
Local type I IFN receptor signaling protects against virus spread within the central nervous system. J Immunol (2009) 1.57
Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction. Virology (2006) 1.56
Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J Virol (2003) 1.53
The IFN-independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. J Immunol (2006) 1.52
Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J Virol (2007) 1.48
Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis. J Virol (2008) 1.48
Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis. J Immunol (2008) 1.48
Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis. J Infect Dis (2007) 1.43
Herpes simplex virus, meningitis and encephalitis in neonates. Herpes (2004) 1.41
EXPERIMENTAL INDUCTION OF DISCIFORM KERATITIS. Arch Ophthalmol (1965) 1.40
The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol (2008) 1.36
A locus on mouse chromosome 6 that determines resistance to herpes simplex virus also influences reactivation, while an unlinked locus augments resistance of female mice. J Virol (2003) 1.32
Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2. J Virol (2006) 1.27
Microglial cells initiate vigorous yet non-protective immune responses during HSV-1 brain infection. Virus Res (2006) 1.18
Herpes simplex virus virion host shutoff attenuates establishment of the antiviral state. J Virol (2008) 1.18
Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing? J Neuroimmunol (2009) 1.16
Hematopoietic cell-derived interferon controls viral replication and virus-induced disease. Blood (2008) 1.09
Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am J Ophthalmol (2006) 1.08
Enhanced pathogenesis of an attenuated herpes simplex virus for mice lacking Stat1. J Virol (2008) 1.02
Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors. Clin Infect Dis (2009) 1.02
Herpes simplex virus type 1 encephalitis is associated with elevated levels of F2-isoprostanes and F4-neuroprostanes. J Neurovirol (2002) 1.02
Effects of CXCR3 signaling on development of fatal encephalitis and corneal and periocular skin disease in HSV-infected mice are mouse-strain dependent. Invest Ophthalmol Vis Sci (2007) 1.01
ICP0 prevents RNase L-independent rRNA cleavage in herpes simplex virus type 1-infected cells. J Virol (2006) 0.94
Concurrent herpes simplex type 1 necrotizing encephalitis, cytomegalovirus ventriculoencephalitis and cerebral lymphoma in an AIDS patient. Acta Neuropathol (1995) 0.91
Control of herpes simplex virus replication is mediated through an interferon regulatory factor 3-dependent pathway. J Virol (2009) 0.90
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe (2007) 7.34
Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc Natl Acad Sci U S A (2001) 5.59
IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A (2007) 3.98
Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood (2003) 3.98
Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J Virol (2002) 2.31
Construction and characterization of bacterial artificial chromosomes containing HSV-1 strains 17 and KOS. J Virol Methods (2006) 1.71
Analysis of the role of autophagy in replication of herpes simplex virus in cell culture. J Virol (2007) 1.63
Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J Virol (2003) 1.53
Pathogenesis of herpes simplex virus type 2 virion host shutoff (vhs) mutants. J Virol (2002) 1.39
Herpes simplex virus type 1 origins of DNA replication play no role in the regulation of flanking promoters. J Virol (2002) 1.23
Functional genomic analysis of herpes simplex virus type 1 counteraction of the host innate response. J Virol (2006) 1.21
Herpes simplex virus virion host shutoff attenuates establishment of the antiviral state. J Virol (2008) 1.18
CD8(+) T cells control corneal disease following ocular infection with herpes simplex virus type 1. J Gen Virol (2004) 1.09
The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0. J Virol (2002) 1.08
Incorporation of three endocytosed varicella-zoster virus glycoproteins, gE, gH, and gB, into the virion envelope. J Virol (2005) 1.04
Host responses to wild-type and attenuated herpes simplex virus infection in the absence of Stat1. J Virol (2008) 1.04
Herpes simplex virus γ34.5 interferes with autophagosome maturation and antigen presentation in dendritic cells. MBio (2012) 1.03
Luciferase real-time bioluminescence imaging for the study of viral pathogenesis. Methods Mol Biol (2005) 1.02
Enhanced pathogenesis of an attenuated herpes simplex virus for mice lacking Stat1. J Virol (2008) 1.02
Therapeutic vaccination with vhs(-) herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice. J Gen Virol (2002) 1.02
Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro model of immune migration across the blood brain barrier. J Neurosci Methods (2012) 0.98
Role of the VP16-binding domain of vhs in viral growth, host shutoff activity, and pathogenesis. J Virol (2004) 0.96
Bioluminescent imaging reveals divergent viral pathogenesis in two strains of Stat1-deficient mice, and in αßγ interferon receptor-deficient mice. PLoS One (2011) 0.93
Synergistic control of herpes simplex virus pathogenesis by IRF-3, and IRF-7 revealed through non-invasive bioluminescence imaging. Virology (2013) 0.93
Transgenic reporter mouse for bioluminescence imaging of herpes simplex virus 1 infection in living mice. Virology (2006) 0.93
Functional genomics reveals an essential and specific role for Stat1 in protection of the central nervous system following herpes simplex virus corneal infection. J Virol (2011) 0.92
Xenophagy in herpes simplex virus replication and pathogenesis. Autophagy (2007) 0.92
Control of herpes simplex virus replication is mediated through an interferon regulatory factor 3-dependent pathway. J Virol (2009) 0.90
In vivo replication of an ICP34.5 second-site suppressor mutant following corneal infection correlates with in vitro regulation of eIF2 alpha phosphorylation. J Virol (2003) 0.89
RNase L activity does not contribute to host RNA degradation induced by herpes simplex virus infection. J Gen Virol (2003) 0.89
Interferon gamma is not required for recurrent herpetic stromal keratitis. Virology (2008) 0.87
Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1. J Immunol (2011) 0.86
The virion host shutoff protein of herpes simplex virus type 1 has RNA degradation activity in primary neurons. J Virol (2004) 0.86
Corneal replication is an interferon response-independent bottleneck for virulence of herpes simplex virus 1 in the absence of virion host shutoff. J Virol (2012) 0.79